Rubius Therapeutics has pulled in another $100 million to fund the advance of its red blood cell therapies. The crossover round, which brings Rubius’ nine-month haul up to $220 million, comes as the ...

Rubius Therapeutics has torn up its strategy. After reviewing human data on its lead candidates, the cell therapy biotech concluded investment in its two clinical prospects “is no longer justified,” ...

Rubius Therapeutics went public in 2018 at a $2 billion valuation — the largest biotech stock market debut at that time. On Wednesday, the company — battered down to a market value of $15 million — ...

Cell therapy is one of the big ideas in biotech. Entrepreneurs have become captivated by possibilities of engineering white blood cells so they can be re-infused into patients and fight cancer. One ...

Rubius Therapeutics Inc. has raised $120 million on the promise that its technology for using cells to treat disease will lead to new ways to attack cancer, infections, rare disorders and other ...

¿Quién es ‘El Rubius’, el streamer de Twitch y youtuber que ahora está acusado de evadir impuestos? ‘El Rubius’, cuyo nombre real es Rubén Doblas Gundersen, es un youtuber y streamer que ha sido ...